EV-302 Patient-Reported Outcomes

Shilpa Gupta, MD, from the Cleveland Clinic in Cleveland, Ohio, shares her findings on patient-reported outcomes from the EV-302 clinical trial with Amanda Nizam, MD.

Drs. Gupta and Nizam discuss the unique aspects of the trial, highlighting the impact of enfortumab vedotin and pembrolizumab on progression-free survival and overall survival in metastatic urothelial carcinoma.

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Oncology Brothers Event Coverage

Advancements in Oncology

GU Oncology Now has exclusive coverage of Advancement in Oncology: Today’s Data for Tomorrow’s Practice, the first event co-hosted by The Oncology Brothers and Mashup Media. Access insights from esteemed experts on the breakthrough genitourinary cancer data presented at the event.

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Vishnu MurthyCRPC | July 8, 2024
Vishnu Murthy discusses the real-world efficacy and toxicity of 177Lu-PSMA-617 for mCRPC.
View More
Rana McKay, MDRenal Cell Carcinoma Diagnostics | June 25, 2024
Rana McKay, MD, provides commentary on the safety of 89Zr-girentuximab PET/CT for treating clear cell renal cell carcinoma.
Jérémie Calais, MD, PhDRLT | June 20, 2024
Dr. Calais provides his list of the clinical trials of interest on imaging, RLT, and prostate cancer from the SNMMI meeting.
Jérémie Calais, MD, PhDRLT | June 20, 2024
Dr. Calais shares his thoughts on the sessions or abstracts that are of the most importance for practicing GU oncologists.

Video Insights

Clinical discussions with experts in the field

Network Websites